Warfarin Use in Nursing Home Residents: Results from the 2004 National Nursing Home Survey

Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study, JAMA, 285, 2370, 10.1001/jama.285.18.2370 Lakshminarayan, 2008, Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the united states, Neurologist, 14, 143, 10.1097/NRL.0b013e31815cffae Singer, 2008, Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition), Chest, 133, 546S, 10.1378/chest.08-0678 Goldstein, 2006, Circulation, 113, e873, 10.1161/01.STR.0000223048.70103.F1 Fuster, 2006, Europace, 8, 651, 10.1093/europace/eul097 Hart, 1999, Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis, Ann Intern Med, 131, 492, 10.7326/0003-4819-131-7-199910050-00003 Mant, 2007, Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged study, BAFTA): a randomised controlled trial, Lancet, 370, 493, 10.1016/S0140-6736(07)61233-1 Connolly, 2009, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med, 360, 2066, 10.1056/NEJMoa0901301 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Fick, 2003, Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts, Arch Intern Med, 163, 2716, 10.1001/archinte.163.22.2716 Lackner, 1995, Use of warfarin for nonvalvular atrial fibrillation in nursing home patients, Arch Fam Med, 4, 1017, 10.1001/archfami.4.12.1017 McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med. 200;161:2458–2463. Perera, 2009, The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation, Age Ageing, 38, 15662 Hutten, 1999, Safety of treatment with oral anticoagulants in the elderly, Drugs Aging, 14, 303, 10.2165/00002512-199914040-00005 Pautas, 2006, Haemorrhagic complications of vitamin K antagonists in the elderly: risk factors and management, Drugs Aging, 23, 13, 10.2165/00002512-200623010-00002 Sebastian, 2000, Use of oral anticoagulants in older patients, Drugs Aging, 16, 409, 10.2165/00002512-200016060-00003 Wynne, 1995, The influence of age, liver size and enantiomer concentrations on warfarin requirements, Br J Clin Pharmacol, 40, 203 Kamali, 2004, Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin, Clin Pharmacol Ther, 75, 204, 10.1016/j.clpt.2003.10.001 Gurwitz, 1992, Aging and the anticoagulant response to warfarin therapy, Ann Intern Med, 116, 901, 10.7326/0003-4819-116-11-901 Redwood, 1991, The association of age with dosage requirement for warfarin, Age Ageing, 20, 217, 10.1093/ageing/20.3.217 Garcia, 2005, Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population, Chest, 127, 2049, 10.1378/chest.127.6.2049 Wynne, 1996, Effect of ageing upon warfarin dose requirements: a longitudinal study, Age Ageing, 25, 429, 10.1093/ageing/25.6.429 Rubenstein, 1994, Falls in the nursing home, Ann Intern Med, 121, 442, 10.7326/0003-4819-121-6-199409150-00009 Gurwitz, 2007, The safety of warfarin therapy in the nursing home setting, Am J Med, 120, 539, 10.1016/j.amjmed.2006.07.045 1990, The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation, N Engl J Med, 323, 1505, 10.1056/NEJM199011293232201 1991, Stroke prevention in atrial fibrillation study, Circulation, 84, 527, 10.1161/01.CIR.84.2.527 Ezekowitz, 1992, Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation, N Engl J Med, 327, 1406, 10.1056/NEJM199211123272002 Birman-Deych, 2006, Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation, Stroke, 37, 1070, 10.1161/01.STR.0000208294.46968.a4 Cohen, 2000, Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission, Stroke, 31, 1217, 10.1161/01.STR.31.6.1217 Gage, 2000, Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation, Stroke, 31, 822, 10.1161/01.STR.31.4.822 Gurwitz, 1997, Atrial fibrillation and stroke prevention with warfarin in the long-term care setting, Arch Intern Med, 157, 978, 10.1001/archinte.1997.00440300080006 Meyers, 2011, Stroke and transient ischemic attack in the long-term care setting: patient characteristics, medication treatment, and length of stay, Consult Pharm, 26, 170, 10.4140/TCP.n.2011.170 Kokotailo, 2005, Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10, Stroke, 36, 1776, 10.1161/01.STR.0000174293.17959.a1 Agarwal, 2010, Predictors of warfarin use in atrial fibrillation patients in the inpatient setting, Am J Cardiovasc Drugs, 10, 37, 10.2165/11318870-000000000-00000 Waldo, 2005, Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation, J Am Coll Cardiol, 46, 1729, 10.1016/j.jacc.2005.06.077 Fuster, 2001, Circulation, 104, 2118, 10.1161/circ.104.17.2118 Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 2011 Beyth, 1998, Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin, Am J Med, 105, 91, 10.1016/S0002-9343(98)00198-3 Pisters, 2010, A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey, Chest, 138, 1093, 10.1378/chest.10-0134 Birman-Deych, 2005, Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors, Med Care, 43, 480, 10.1097/01.mlr.0000160417.39497.a9 Benesch, 1997, Inaccuracy of the international classification of diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease, Neurology, 49, 660, 10.1212/WNL.49.3.660 Angus, 2001, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Crit Care Med, 29, 1303, 10.1097/00003246-200107000-00002 Martin, 2003, The epidemiology of sepsis in the united states from 1979 through 2000, N Engl J Med, 348, 1546, 10.1056/NEJMoa022139 Rinaldi, 2003, Accuracy of ICD-9 codes in identifying ischemic stroke in the General Hospital of Lugo Di Romagna (Italy), Neurol Sci, 24, 65, 10.1007/s100720300074 Andrade, 2002, Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study, J Clin Epidemiol, 55, 310, 10.1016/S0895-4356(01)00480-2 Raiford, 1996, Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan Hospital automated database, Epidemiology, 7, 101, 10.1097/00001648-199601000-00018 Kiyota, 2004, Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records, Am Heart J, 148, 99, 10.1016/j.ahj.2004.02.013 Christian, 2003, Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents, Stroke, 34, 2693, 10.1161/01.STR.0000096993.90248.27 Liangos, 2006, Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey, Clin J Am Soc Nephrol, 1, 43, 10.2215/CJN.00220605 Rollason, 2003, Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist, Drugs Aging, 20, 817, 10.2165/00002512-200320110-00003 2002, The use of oral anticoagulants (warfarin) in older people, J Am Geriatr Soc, 50, 1439, 10.1046/j.1532-5415.2002.50380.x Bradley, 2000, Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center, Am J Cardiol, 85, 568, 10.1016/S0002-9149(99)00813-9 Gage, 2000, Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation, Stroke, 31, 822, 10.1161/01.STR.31.4.822 Tulner, 2010, Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study, Drugs Aging, 27, 39, 10.2165/11319540-000000000-00000 Bungard, 2000, Why do patients with atrial fibrillation not receive warfarin?, Arch Intern Med, 160, 41, 10.1001/archinte.160.1.41 Monette, 1997, Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners, J Am Geriatr Soc, 45, 1060, 10.1111/j.1532-5415.1997.tb05967.x Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Freeman, 2011, Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation, Ann Intern Med, 154, 1, 10.7326/0003-4819-154-1-201101040-00289 Legrand, 2011, The use of dabigatran in elderly patients, Arch Intern Med, 171, 1285, 10.1001/archinternmed.2011.314 Johnston, 2003, Predictors of warfarin use among ohio Medicaid patients with new-onset nonvalvular atrial fibrillation, Arch Intern Med, 163, 1705, 10.1001/archinte.163.14.1705 Go, 1999, Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study, Ann Intern Med, 131, 927, 10.7326/0003-4819-131-12-199912210-00004 Friberg, 2006, Stroke prophylaxis in atrial fibrillation: who gets it and who does not?, Eur Heart J, 27, 1954, 10.1093/eurheartj/ehl146 Poli, 2009, Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years, J Am Coll Cardiol, 54, 999, 10.1016/j.jacc.2009.05.046 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation, Arch Intern Med, 154, 1449, 10.1001/archinte.1994.00420130036007 Holbrook, 2005, Systematic overview of warfarin and its drug and food interactions, Arch Intern Med, 165, 1095, 10.1001/archinte.165.10.1095 Verhovsek, 2008, Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review, BMC Geriatr, 8, 13, 10.1186/1471-2318-8-13 Gage, 2006, Clinical classification schemes for predicting hemorrhage: results from the national registry of atrial fibrillation (NRAF), Am Heart J, 151, 713, 10.1016/j.ahj.2005.04.017 Beyth, 1998, Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin, Am J Med, 105, 91, 10.1016/S0002-9343(98)00198-3